AUSTIN, Texas, July 14, 2022 (GLOBE NEWSWIRE) -- Today, at HA Connect!, the 17th annual national conference on hydrocephalus, Hyperfine—creator of Swoop®, the first FDA-cleared portable magnetic ...
Multi-site observational study seeks to redefine the standard of care for pediatric hydrocephalus management GUILFORD, Conn.--(BUSINESS WIRE)-- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA has granted 510(k) clearance to a radiology ...
WAKEFIELD, Mass.--(BUSINESS WIRE)--Myrtelle Inc. (“Myrtelle” or the “Company”), a gene therapy company focused on developing transformative treatments for neurodegenerative diseases, today announced ...
Researchers at the University of Eastern Finland have identified a new geometric marker of the brain ventricles that could ...
When you hear the words ‘water on the brain,’ it instantly sounds frightening. But behind that phrase is a condition called hydrocephalus, which, while serious, is also treatable with the right care.
Cerebrospinal fluid shunting improved walking speed, gait, and balance in older adults with idiopathic normal-pressure hydrocephalus. An open-shunt valve setting led to no significant improvements in ...
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop ® system, the world’s first FDA-cleared portable magnetic resonance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results